Exhibit 23.2
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in this Registration Statement of Conduit Pharmaceuticals, Inc. on Form S-8 of our report dated May 12, 2023 which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the financial statements of Conduit Pharmaceuticals, Ltd. as of December 31, 2022 and 2021 and for the years then ended.
| /s/ Marcum llp | |
| Marcum llp | |
| New York, New York | |
| December 1, 2023 |
